Dr. Cooper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 E 210th St
Bronx, NY 10467Phone+1 718-920-4826Fax+1 732-235-8094
Education & Training
UPMC Medical EducationResidency, Internal Medicine, 1982 - 1983
Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
Rush Medical College of Rush University Medical CenterClass of 1979- Yale-New Haven Medical CenterFellowship, Medical Oncology
Certifications & Licensure
CT State Medical License 1981 - 2026
NY State Medical License 2022 - 2026
NJ State Medical License 2015 - 2023
PA State Medical License 1982 - 1984
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.Othman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi, Mark Forsberg, Metodi Balev
British Journal of Haematology. 2024-11-01 - Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database.John Yan, M Bakri Hammami, John X Wei, Nishi Shah, Mendel Goldfinger
Annals of Hematology. 2024-09-01 - A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia.Steve Kong, Sanjana Nagraj, Dennis L Cooper, Kevin J Ferrick, Lili Zhang
Cardio-Oncology. 2024-08-09
Abstracts/Posters
- Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow upDennis Cooper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution S...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
